Stockscreener 앱 받기
3.06
4.38%
-0.14
전일 마감가:
$3.20
열려 있는:
$3.2
하루 거래량:
40,967
Relative Volume:
0.46
시가총액:
$112.32M
수익:
$306.00K
순이익/손실:
$-36.24M
주가수익비율:
-2.6379
EPS:
-1.16
순현금흐름:
$-27.32M
1주 성능:
-5.85%
1개월 성능:
-0.33%
6개월 성능:
-1.61%
1년 성능:
-52.11%
1일 변동 폭
$3.023
$3.25
1주일 범위
$3.023
$3.292
52주 변동 폭
$1.37
$9.1297
Sera Prognostics Inc Stock (SERA) Company Profile
명칭
Sera Prognostics Inc
전화
(801) 990-0520
주소
2749 E. PARLEYS WAY, SALT LAKE CITY
SERA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
3.06 | 121.80M | 306.00K | -36.24M | -27.32M | -1.16 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | Oppenheimer | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
Sera Prognostics Inc 주식(SERA)의 최신 뉴스
Signal strength of Sera Prognostics Inc. stock in tech scannersEarnings Performance Report & Weekly High Return Stock Opportunities - newser.com
How to use Fibonacci retracement on Sera Prognostics Inc.July 2025 Price Swings & High Conviction Trade Alerts - newser.com
What indicators show strength in Sera Prognostics Inc.2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Is Sera Prognostics Inc. stock cheap at current valuationPortfolio Performance Report & Accurate Technical Buy Alerts - newser.com
Will Sera Prognostics Inc. stock outperform Dow Jones indexJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com
Candlestick signals on Sera Prognostics Inc. stock todayMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Pattern recognition hints at Sera Prognostics Inc. upsideBreakout Watch & Capital Efficient Trade Techniques - newser.com
How buybacks impact Sera Prognostics Inc. stock valueJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
What drives Sera Prognostics Inc stock priceBull Market Opportunities & Minimal Capital Growth Plans - earlytimes.in
Sera Prognostics (NASDAQ:SERA) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Will Sera Prognostics Inc. continue its uptrendQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Published on: 2025-10-09 02:25:33 - newser.com
Published on: 2025-10-09 05:14:41 - earlytimes.in
Insider Sell: Robert Harrison Sells 2,000 Shares of Sera Prognos - GuruFocus
Sera prognostics CIO Harrison sells $6360 in stock By Investing.com - Investing.com Canada
What analysts say about Sera Prognostics Inc stockValue Stock Picks & High Profit Trading Signals - earlytimes.in
Identifying reversal signals in Sera Prognostics Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - newser.com
What Fibonacci levels say about Sera Prognostics Inc. reboundTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Will a bounce in Sera Prognostics Inc. offer an exitPortfolio Value Summary & Weekly High Momentum Picks - newser.com
Should you wait for a breakout in Sera Prognostics Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Tools to assess Sera Prognostics Inc.’s risk profileWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer By Investing.com - Investing.com Nigeria
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer - Investing.com
Women's Health Pioneer Sera Prognostics Taps OBGYN Leader Dr. Inglis to Drive PreTRM Test Adoption - Stock Titan
Detecting support and resistance levels for Sera Prognostics Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Sera Prognostics Inc (SERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.83%
자본화:
|
볼륨(24시간):